How we’re accelerating the radiopharmaceutical clinical workflow

OUR VISION

We aim to drastically improve health outcomes through vastly increased utilization of radiopharmaceuticals

How we’ll achieve this with microscale innovation

OUR VISION

We aim to drastically improve health outcomes through vastly increased utilization of radiopharmaceuticals

How we’ll achieve this with microscale innovation

OUR VISION

We aim to drastically improve health outcomes through vastly increased utilization of radiopharmaceuticals

How we’ll achieve this with microscale innovation

Our Microscale Workflow

FROM ACCELERATED DISCOVERY...

Discover vast sets of compounds in weeks, without capital investments

DropletPharma offers both compound screening and fast optimization at 50-100x speeds while helping you avoid capital investments - giving you wide berth to expand your clinical pipeline and accelerate timelines to IND approval.

How our microscale discovery platform is so rapid

FROM ACCELERATED DISCOVERY...

Discover vast sets of compounds in weeks, without capital investments

DropletPharma offers both compound screening and fast optimization at 50-100x speeds while helping you avoid capital investments - giving you wide berth to expand your clinical pipeline and accelerate timelines to IND approval.

How our microscale discovery platform is so rapid

...TO WIDE REACH AND FAST APPROVAL...

Establishing robust supply at many sites to support rapid setup of clinical trials

Whether you initiated your study with us or want to shift your R&D to us - we will take your lead candidate to a wider geography of clinical sites faster and cheaper than current timelines.

How we establish supply so quickly

... TO VAST AND ROBUST DISTRIBUTION.

Turning trial sites and adding more to build robust national distribution

The DropletPharma unified platform aims to eliminate years of development time, hasten clinical trials expansion, and enable immediate distribution upon approval - leading to years of additional revenue for the drugmaker, reducing failed radiopharma clinical trials, and accelerating investment into the sector.

How we eliminate friction and accelerate time-to-market

For academic researchers or pharmaceutical companies

If you are looking to bring a radiopharmaceutical to market, or a radiopharmaceutical companion diagnostic for your clinical trial, we would love to help you advance your research or drug program without any capital investment necessary on your part and are not limited by any isotope or compound!

Contact us!

... TO VAST AND ROBUST DISTRIBUTION.

Turning trial sites and adding more to build robust national distribution

The DropletPharma unified platform will eventually eliminate years of development, hasten clinical trials expansion, and enable immediate distribution upon approval - leading to years of additional revenue for the drugmaker and aiming to accelerate investment into the sector.

How we eliminate friction and accelerate time-to-market

...TO WIDE REACH AND FAST APPROVAL...

Establishing robust supply at many sites to support rapid setup of clinical trials

Whether you initiated or want to shift your drug discovery to us - at DropletPharma, we will take it to clinical trials and expand to a wider geography of clinical sites faster and cheaper than before.

How we establish supply so quickly

... TO VAST AND ROBUST DISTRIBUTION.

Turning trial sites and adding more to build robust national distribution

The DropletPharma unified platform will eventually eliminate years of development, hasten clinical trials expansion, and enable immediate distribution upon approval - leading to years of additional revenue for the drugmaker and aiming to accelerate investment into the sector.

How we eliminate friction and accelerate time-to-market

...TO WIDE REACH AND FAST APPROVAL...

Establishing robust supply at many sites to support rapid setup of clinical trials

Whether you initiated or want to shift your drug discovery to us - at DropletPharma, we will take it to clinical trials and expand to a wider geography of clinical sites faster and cheaper than before.